2
Clinical Trials associated with IVB-103 / Active, not recruitingPhase 1 An Exploratory Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of IVB103 Injection in Subjects with Neovascular (wet) Agerelated Macular Degeneration (nAMD).
The goal of this clinical trial is to evaluate the safety and efficacy of IVB103 injection in subjects with nAMD.
/ Not yet recruitingPhase 1/2 一项在新生血管性(湿性)年龄相关性黄斑变性(nAMD)受试者中评价IVB103 注射液的安全性,耐受性和疗效探索性临床试验
[Translation] An exploratory clinical trial evaluating the safety, tolerability and efficacy of IVB103 injection in subjects with neovascular (wet) age-related macular degeneration (nAMD)
本研究旨在评价IVB103注射液在nAMD受试者中单次玻璃体内给药的安全性、耐受性和初步有效性。本研究由第一阶段剂量递增研究(I期)和第二阶段疗效探索研究(II期)组成。
[Translation] This study aims to evaluate the safety, tolerability and preliminary efficacy of a single intravitreal administration of IVB103 injection in subjects with nAMD. This study consists of a Phase I dose escalation study (Phase I) and a Phase II efficacy exploration study (Phase II).
100 Clinical Results associated with IVB-103
100 Translational Medicine associated with IVB-103
100 Patents (Medical) associated with IVB-103
100 Deals associated with IVB-103